Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026)
Akebia Therapeutics' Prepaid Assets was $7.48 million in Q2 2026, down 4.5% from $7.83 million a year earlier but up 41.0% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Prepaid Assets at Akebia Therapeutics came in at $5.47 million, down 51.8% from FY2024.
- Prepaid Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -18.1% (FY2020 to FY2025).
- In earlier years, Prepaid Assets was $11.35 million in FY2024 (-43.9%), $20.24 million in FY2023 (-38.4%), $32.86 million in FY2022 (-0.8%) and $33.14 million in FY2021 (+122.8%).
- Quarterly Prepaid Assets has moved between $5.31 million (Q1 2026) and $42.13 million (Q2 2022) over five years.
- Compared with a year earlier, Prepaid Assets has declined for 13 straight quarters, with an average decline of 42.4% over the last eight quarters.
- The best year-over-year quarter for Prepaid Assets over five years was Q3 2021 (growth of 337.1%); the worst was Q2 2025 (a decline of 58.7%).
- Per Business Quant data, AKBA's Prepaid Assets in the three quarters before Q2 2026 was $5.31 million (Q1 2026), $5.47 million (Q4 2025) and $7.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.48 Mn |
| Mar 31, 2026 | 5.31 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Sep 30, 2024 | 13.44 Mn |
| Jun 30, 2024 | 18.96 Mn |
| Mar 31, 2024 | 18.83 Mn |
| Dec 31, 2023 | 20.24 Mn |
| Sep 30, 2023 | 22.04 Mn |
| Jun 30, 2023 | 24.40 Mn |
| Mar 31, 2023 | 24.70 Mn |
| Dec 31, 2022 | 32.86 Mn |
| Sep 30, 2022 | 28.94 Mn |
| Jun 30, 2022 | 42.13 Mn |
| Mar 31, 2022 | 24.12 Mn |
| Dec 31, 2021 | 33.14 Mn |
| Sep 30, 2021 | 39.50 Mn |
API Access
Akebia Therapeutics Prepaid Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=prepaid-assets&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "prepaid-assets", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=prepaid-assets&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();